• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠状动脉疾病患者的高血压管理]

[Management of hypertension in patients with coronary artery disease].

作者信息

Sato M, Hasebe N, Kikuchi K

机构信息

First Department of Internal Medicine, Asahikawa Medical College.

出版信息

Nihon Rinsho. 2001 May;59(5):949-54.

PMID:11391997
Abstract

The management of hypertensive patients with coronary artery disease (CAD) should be started with lifestyle modification for reduction of coronary risk factors. As the principle of drug therapy, rapid decrease in blood pressure below the limits of coronary auto-regulation must be avoided. Clinical trials showed J-curved relationship between diastolic pressure and mortality was not found above 75 mmHg. The current desired goal of blood pressure in patients with CAD might be suggested as 125-140/85-75 mmHg. Pulse pressure should be recognized as a strong predictor for CAD as well as systolic and diastolic blood pressure, especially in elderly patients. The choice of drug therapy have to be based on efficiency in clinical trials, side effects, and also particular condition of each patient.

摘要

对于患有冠状动脉疾病(CAD)的高血压患者,管理应从改善生活方式以降低冠状动脉危险因素开始。作为药物治疗的原则,必须避免血压快速降至冠状动脉自动调节范围以下。临床试验表明,舒张压与死亡率之间未发现J形曲线关系高于75 mmHg。目前,CAD患者的血压目标可能建议为125 - 140/85 - 75 mmHg。脉压应被视为CAD以及收缩压和舒张压的有力预测指标,尤其是在老年患者中。药物治疗的选择必须基于临床试验中的疗效、副作用以及每个患者的特殊情况。

相似文献

1
[Management of hypertension in patients with coronary artery disease].[冠状动脉疾病患者的高血压管理]
Nihon Rinsho. 2001 May;59(5):949-54.
2
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
3
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.高血压合并冠状动脉疾病患者的脉压与心血管事件风险:一项国际维拉帕米缓释片 - 群多普利研究(INVEST)分析
Eur Heart J. 2009 Jun;30(11):1395-401. doi: 10.1093/eurheartj/ehp109. Epub 2009 Apr 7.
4
[Hypertension management in general practice in Iceland].[冰岛全科医疗中的高血压管理]
Laeknabladid. 2006 May;92(5):375-80.
5
Actual blood pressure control: are we doing things right?实际的血压控制:我们做得对吗?
J Hypertens Suppl. 1998 Jan;16(1):S45-51.
6
[Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].[高血压治疗的目标值。它们是否适用于老年高血压患者、糖尿病患者和缺血性心脏病患者?]
Vnitr Lek. 2009 Sep;55(9):833-40.
7
[Hypertension as a function of age].[高血压与年龄的关系]
Ital Heart J. 2000 Jun;1 Suppl 2:23-31.
8
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
9
Risk stratification for the prevention of cardiovascular complications of hypertension.高血压心血管并发症预防的风险分层
Curr Med Res Opin. 2004 Jul;20(7):1137-42. doi: 10.1185/030079904125004169.
10
Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.经治疗的高血压患者中的中风和冠心病——一项长达三十年的前瞻性队列研究
J Intern Med. 2005 Jun;257(6):496-502. doi: 10.1111/j.1365-2796.2005.01497.x.

引用本文的文献

1
Post-exercise differential response of central and brachial blood pressure in patients with coronary artery disease: A randomized crossover trial.冠心病患者运动后中心血压与肱动脉血压的差异反应:一项随机交叉试验。
PLoS One. 2025 Feb 21;20(2):e0317212. doi: 10.1371/journal.pone.0317212. eCollection 2025.